ReviewExploration of targeted anti-tumor therapy2025

Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer.

Laura Valerio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.